LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation.

Chernyaeva, Larisa / Ratti, Giorgio / Teirilä, Laura / Fudo, Satoshi / Rankka, Uni / Pelkonen, Anssi / Korhonen, Paula / Leskinen, Katarzyna / Keskitalo, Salla / Salokas, Kari / Gkolfinopoulou, Christina / Crompton, Katrina E / Javanainen, Matti / Happonen, Lotta / Varjosalo, Markku / Malm, Tarja / Leinonen, Ville / Chroni, Angeliki / Saavalainen, Päivi /
Meri, Seppo / Kajander, Tommi / Wollman, Adam Jm / Nissilä, Eija / Haapasalo, Karita

EMBO reports

2023  Volume 24, Issue 7, Page(s) e56467

Abstract: The APOE4 variant of apolipoprotein E (apoE) is the most prevalent genetic risk allele associated with late-onset Alzheimer's disease (AD). ApoE interacts with complement regulator factor H (FH), but the role of this interaction in AD pathogenesis is ... ...

Abstract The APOE4 variant of apolipoprotein E (apoE) is the most prevalent genetic risk allele associated with late-onset Alzheimer's disease (AD). ApoE interacts with complement regulator factor H (FH), but the role of this interaction in AD pathogenesis is unknown. Here we elucidate the mechanism by which isoform-specific binding of apoE to FH alters Aβ1-42-mediated neurotoxicity and clearance. Flow cytometry and transcriptomic analysis reveal that apoE and FH reduce binding of Aβ1-42 to complement receptor 3 (CR3) and subsequent phagocytosis by microglia which alters expression of genes involved in AD. Moreover, FH forms complement-resistant oligomers with apoE/Aβ1-42 complexes and the formation of these complexes is isoform specific with apoE2 and apoE3 showing higher affinity to FH than apoE4. These FH/apoE complexes reduce Aβ1-42 oligomerization and toxicity, and colocalize with complement activator C1q deposited on Aβ plaques in the brain. These findings provide an important mechanistic insight into AD pathogenesis and explain how the strongest genetic risk factor for AD predisposes for neuroinflammation in the early stages of the disease pathology.
MeSH term(s) Humans ; Apolipoprotein E4/genetics ; Apolipoprotein E4/metabolism ; Complement Factor H/genetics ; Alzheimer Disease/genetics ; Alzheimer Disease/metabolism ; Neuroinflammatory Diseases ; Apolipoproteins E/chemistry ; Apolipoproteins E/genetics ; Apolipoproteins E/metabolism ; Amyloid beta-Peptides/metabolism ; Protein Isoforms/genetics ; Protein Isoforms/metabolism
Chemical Substances Apolipoprotein E4 ; Complement Factor H (80295-65-4) ; Apolipoproteins E ; Amyloid beta-Peptides ; Protein Isoforms
Language English
Publishing date 2023-05-08
Publishing country England
Document type Journal Article
ZDB-ID 2020896-0
ISSN 1469-3178 ; 1469-221X
ISSN (online) 1469-3178
ISSN 1469-221X
DOI 10.15252/embr.202256467
Shelf mark
Zs.A 5433: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MG 41: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top